(Q61831096)
Statements
Oral iloprost in Raynaud's phenomenon secondary to systemic sclerosis: a multicentre, placebo-controlled, dose-comparison study (English)
C M Black
L Halkier-Sørensen
S Ullman
R Madhok
A J Smit
J D Banga
1 September 1998